The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract

Curr Allergy Asthma Rep. 2017 Mar;17(3):16. doi: 10.1007/s11882-017-0685-2.

Abstract

Viral infections are leading causes of both upper and lower airway acute illness in all age groups of healthy persons, and have also been implicated in the acute exacerbations of chronic respiratory disorders like asthma and COPD. Human rhinovirus, respiratory syncytial virus, influenza virus and coronavirus have been considered as the most important respiratory pathogens and relatively little attention has been paid to the role of parainfluenza viruses (hPIVs). Human parainfluenza viruses are single-stranded RNA viruses belonging to the paramyxovirus family that may evoke lower respiratory infections in infants, children and immunocompromised individuals. Among non-immune compromised adults, hPIV infection typically causes mild disease manifested as upper respiratory tract symptoms and is infrequently associated with severe croup or pneumonia. Moreover, hPIV infection may be associated with viral exacerbations of chronic airway diseases, asthma or COPD or chronic rhinosinusitis. In this review, we summarized the basic epidemiology and immunology of hPIVs and addressed the more recent data implicating the role of parainfluenza viruses in the exacerbation of chronic airway disorders.

Keywords: Airway diseases; Asthma exacerbations; Innate response; Parainfluenza viruses; Respiratory viral infections; Vaccines.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Humans
  • Paramyxoviridae Infections* / drug therapy
  • Paramyxoviridae Infections* / epidemiology
  • Paramyxoviridae Infections* / immunology
  • Paramyxoviridae Infections* / pathology
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / immunology
  • Respiratory Tract Infections / pathology
  • Respiratory Tract Infections / virology*

Substances

  • Antiviral Agents